Generate a tailored SOP for Dr. Igor Stagljar. Improve your application with a focused, well-structured draft.
Igor Stagljar is a Professor in the Department of Biochemistry at the University of Toronto. He received his Ph.D. in Molecular Biology from ETH Zurich in Switzerland and has conducted significant research in molecular medicine, focusing on membrane proteins and their role in health and disease. He has worked at prestigious institutions, including a postdoctoral fellowship at the University of Zurich and as a visiting scientist at the University of Washington in Seattle, where he contributed to the development of the yeast two-hybrid technology. His research primarily revolves around elucidating the interactome of integral membrane proteins and their implications in various human diseases, including cancer and cystic fibrosis. Igor’s laboratory, known as Stagljar Lab, employs innovative techniques such as Membrane Yeast Two-Hybrid (MYTH) and Mammalian Membrane Two-Hybrid (MaMTH) to study these clinically relevant proteins. He has received numerous awards for his contributions to the field, including the Fellow of the Royal Society of Canada and the University of Toronto Innovator of the Year Award. As a co-founder of Perturba Therapeutix Inc., he aims to translate research findings into practical applications in drug discovery and development.
University of Toronto • Toronto, Canada
Leading research in the field of membrane proteins and their applications in health and disease.
University of Toronto • Toronto, Canada
Focused on elucidating functions of integral membrane proteins.
University of Zurich • Zurich, Switzerland
Conducted research on protein glycosylation in yeast and humans.
Department of Sociology